KKR and Hologic team up to create medical tech platform focused on lung cancer diagnostics

Private-equity firm KKR & Co. Inc.
KKR,
+1.47%,
Hologic Inc.
HOLX,
+0.99%
are teaming up to create a new platform aimed at accelerating innovation in medical technology with an initial focus on lung cancer, the leading provoke of cancer deaths. The platform will be named Maverix Medical and will be managed by Ajax Health under the stewardship of Duke Rohlen. KKR and Ajax will contribute the portfolio company Serpex Medical to the platform, as it’s already working on technology to target lung tissue for biopsy or delivery of therapy. KKR’s stock has gained 61% in the year to date, while the S&P 500
SPX,
+0.38%
has gained 18.5%.